<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000751152"><TermName>OPPA regimen</TermName><TermPronunciation>(... REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination that is often used with radiation therapy to treat a certain type of childhood Hodgkin lymphoma in females. It includes the drugs vincristine sulfate (Oncovin), prednisone, procarbazine hydrochloride, and doxorubicin hydrochloride (Adriamycin). Also called OPPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000752519" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;OPPA regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000752520" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen OPPA&quot;" language="es" id="_4"/><SpanishTermName>régimen OPPA</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de  una quimioterapia combinada que se usa a menudo con radioterapia para tratar cierto tipo de linfoma de Hodgkin infantil en niñas. Se compone de los medicamentos sulfato de vincristina (Oncovin), prednisona, clorhidrato de procarbazina y clorhidrato de doxorrubicina (Adriamycin). También se llama OPPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2013-07-17</DateFirstPublished><DateLastModified>2013-09-20</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000750859">OPPA</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
